NURIX THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
NURIX THERAPEUTICS, INC. (NRIX) reported Basic Shares Outstanding (Weighted Average) of 111.08 million shares for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-09
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-05-31 was 111.08M shares, a 32.43% increase year-over-year.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-02-28 was 110.07M shares, a 31.73% increase year-over-year.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-11-30 was 95.06M shares, a 21.36% increase year-over-year.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-08-31 was 84.16M shares, a 15.64% increase year-over-year.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 86.67M shares, a 29.12% increase from fiscal 2024.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 67.12M shares, a 23.52% increase from fiscal 2023.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 54.34M shares, a 11.79% increase from fiscal 2022.
- NURIX THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 48.61M shares, a 13.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-05-31 | 111.08M shares 10-Q · filed 2026-07-09 | 110.58M shares 10-Q · filed 2026-07-09 | 105.41M shares derived: average of 3 quarters · filed 2026-07-09 | 100.09M shares derived: average of 4 quarters · filed 2026-07-09 |
| 2026-02-28 | 110.07M shares 10-Q · filed 2026-04-08 | 102.57M shares derived: average of 2 quarters · filed 2026-04-08 | 96.43M shares derived: average of 3 quarters · filed 2026-04-08 | 93.29M shares derived: average of 4 quarters · filed 2026-07-09 |
| 2025-11-30 | 95.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-28 | 89.61M shares derived: average of 2 quarters · filed 2026-01-28 | 87.70M shares derived: average of 3 quarters · filed 2026-07-09 | 86.67M shares 10-K · filed 2026-01-28 |
| 2025-08-31 | 84.16M shares 10-Q · filed 2025-10-09 | 84.02M shares derived: average of 2 quarters · filed 2026-07-09 | 83.87M shares 10-Q · filed 2025-10-09 | 82.48M shares derived: average of 4 quarters · filed 2026-07-09 |
| 2025-05-31 | 83.88M shares 10-Q · filed 2026-07-09 | 83.72M shares 10-Q · filed 2026-07-09 | 81.92M shares derived: average of 3 quarters · filed 2026-07-09 | 79.64M shares derived: average of 4 quarters · filed 2026-07-09 |
| 2025-02-28 | 83.56M shares 10-Q · filed 2026-04-08 | 80.94M shares derived: average of 2 quarters · filed 2026-04-08 | 78.22M shares derived: average of 3 quarters · filed 2026-04-08 | 74.26M shares derived: average of 4 quarters · filed 2026-04-08 |
| 2024-11-30 | 78.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-28 | 75.55M shares derived: average of 2 quarters · filed 2026-01-28 | 71.16M shares derived: average of 3 quarters · filed 2026-01-28 | 67.12M shares 10-K · filed 2026-01-28 |
| 2024-08-31 | 72.78M shares 10-Q · filed 2025-10-09 | 67.58M shares derived: average of 2 quarters · filed 2025-10-09 | 63.38M shares 10-Q · filed 2025-10-09 | 61.18M shares derived: average of 4 quarters · filed 2026-01-28 |
| 2024-05-31 | 62.38M shares 10-Q · filed 2025-07-09 | 58.66M shares 10-Q · filed 2025-07-09 | 57.32M shares derived: average of 3 quarters · filed 2026-01-28 | 56.59M shares derived: average of 4 quarters · filed 2026-01-28 |
| 2024-02-29 | 54.90M shares 10-Q · filed 2025-04-08 | 54.79M shares derived: average of 2 quarters · filed 2026-01-28 | 54.65M shares derived: average of 3 quarters · filed 2026-01-28 | 54.56M shares derived: average of 4 quarters · filed 2026-01-28 |
| 2023-11-30 | 54.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-28 | 54.53M shares derived: average of 2 quarters · filed 2026-01-28 | 54.44M shares derived: average of 3 quarters · filed 2026-01-28 | 54.34M shares 10-K · filed 2026-01-28 |
| 2023-08-31 | 54.39M shares 10-Q · filed 2024-10-11 | 54.32M shares derived: average of 2 quarters · filed 2024-10-11 | 54.23M shares 10-Q · filed 2024-10-11 | 54.15M shares derived: average of 4 quarters · filed 2025-01-28 |
| 2023-05-31 | 54.26M shares 10-Q · filed 2024-07-11 | 54.14M shares 10-Q · filed 2024-07-11 | 54.07M shares derived: average of 3 quarters · filed 2025-01-28 | 53.27M shares derived: average of 4 quarters · filed 2025-01-28 |
| 2023-02-28 | 54.03M shares 10-Q · filed 2024-04-10 | 53.98M shares derived: average of 2 quarters · filed 2025-01-28 | 52.94M shares derived: average of 3 quarters · filed 2025-01-28 | 50.93M shares derived: average of 4 quarters · filed 2025-01-28 |
| 2022-11-30 | 53.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-28 | 52.40M shares derived: average of 2 quarters · filed 2025-01-28 | 49.90M shares derived: average of 3 quarters · filed 2025-01-28 | 48.61M shares 10-K · filed 2025-01-28 |
| 2022-08-31 | 50.87M shares 10-Q · filed 2023-10-12 | 47.88M shares derived: average of 2 quarters · filed 2023-10-12 | 46.84M shares 10-Q · filed 2023-10-12 | 46.25M shares derived: average of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | 44.90M shares 10-Q · filed 2023-07-13 | 44.80M shares 10-Q · filed 2023-07-13 | 44.71M shares derived: average of 3 quarters · filed 2023-07-13 | 44.63M shares derived: average of 4 quarters · filed 2023-07-13 |
| 2022-02-28 | 44.69M shares 10-Q · filed 2023-04-13 | 44.62M shares derived: average of 2 quarters · filed 2023-04-13 | 44.54M shares derived: average of 3 quarters · filed 2023-04-13 | 44.36M shares derived: average of 4 quarters · filed 2023-04-13 |
| 2021-11-30 | 44.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | 44.46M shares derived: average of 2 quarters · filed 2023-02-09 | 44.24M shares derived: average of 3 quarters · filed 2023-02-09 | 42.90M shares 10-K · filed 2023-02-09 |
| 2021-08-31 | 44.37M shares 10-Q · filed 2022-10-06 | 44.09M shares derived: average of 2 quarters · filed 2022-10-06 | 42.34M shares 10-Q · filed 2022-10-06 | |
| 2021-05-31 | 43.80M shares 10-Q · filed 2022-07-07 | 41.32M shares 10-Q · filed 2022-07-07 | ||
| 2020-08-31 | 16.94M shares 10-Q · filed 2021-10-14 | 10.33M shares derived: average of 2 quarters · filed 2021-10-14 | 8.05M shares 10-Q · filed 2021-10-14 | |
| 2020-05-31 | 3.73M shares 10-Q · filed 2021-07-13 | 3.64M shares 10-Q · filed 2021-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |